(Bloomberg) -- Nova Biomedical is exploring a potential sale that could value it at more than $2 billion, people with knowledge of the matter said. The privately-held medical device maker is ...

The Nova Primary blood glucose reference analyzer meets the requirements of glucose device manufacturers and clinical researchers for an accurate, user-friendly replacement for the discontinued ...

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Nova Eye Medical Limited (EYE). However, you won't necessarily see their names in the company’s ...